SCHEMBL7216104

SCHEMBL7216104

COC(=O)C1=Cc2cc(OC)ccc2S(=O)(=O)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.49
CA9 Q16790 3/20 0.49
CA2 P00918 3/20 0.49
KDM4E B2RXH2 3/20 0.43
RYR2 Q92736 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
SHMT2 P34897 1/20 0.37
CA1 P00915 1/20 0.37
L3MBTL1 Q9Y468 3/20 0.36
GAA P10253 2/20 0.36
MAPT P10636 2/20 0.36
GLA P06280 1/20 0.36
RAB9A P51151 1/20 0.36
ATM Q13315 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
HTT P42858 2/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7934163 0.90 KDM4E (0.45) CA12CA9CA2KDM4ERYR2
SCHEMBL7222460 0.86 MRGPRX4 (0.47) KDM4ERAB9ATDP1ALDH1A1TP53
SCHEMBL7222517 0.85 CA12 (0.39) CA12CA9CA2KDM4ECA1
SCHEMBL7931558 0.84 CTSL (0.39) CA12CA9CA2KDM4ECYP1A2
SCHEMBL7216635 0.82 LTA4H (0.39) CA12CA9CA2KDM4EGAA
SCHEMBL7215982 0.82 ACACB (0.36) CA12CA9CA2MAPTRAB9A
SCHEMBL7222605 0.82 MAOB (0.44) HTTMAOBNR4A2
SCHEMBL7922057 0.81 MAPT (0.42) KDM4EGAAMAPTRAB9AALDH1A1
SCHEMBL7969016 0.81 CA12 (0.41) CA12CA9CA2KDM4ECYP1A2
SCHEMBL7969027 0.81 CTSL (0.41) CA12CA9L3MBTL1MAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6627651-B1 Exhibiting preventive and therapeutic effects against HIV infectious diseases wherein R1 is an optionally substituted five- or six-membered ring group; X1 is a free valency or the like; W is a divalent group and inhibitors of HIV (human TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-09-30 US disclosed
EP-1182195-A1 CYCLIC COMPOUNDS AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2002-02-27 EP disclosed